C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2002
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266009A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF
12/18/2002	EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand
12/18/2002	EP1266007A1 Human survivin interacting protein 1 (sip-1)
12/18/2002	EP1266003A2 Kcnb: a potassium channel protein
12/18/2002	EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002	EP1265999A2 Human schizophrenia gene
12/18/2002	EP1265998A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics
12/18/2002	EP1265990A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
12/18/2002	EP1265929A1 Anti-c2/c2a inhibitors of complement activation
12/18/2002	EP1265928A1 Ultra high affinity neutralizing antibodies
12/18/2002	EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265918A1 Human immune response proteins
12/18/2002	EP1265917A2 Tlp peptides and dna sequences coding the same
12/18/2002	EP1265916A2 Therapeutic anti-cytomegalovirus compounds
12/18/2002	EP1265915A2 Novel compounds
12/18/2002	EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/18/2002	EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002	EP1265635A1 Pharmaceutical comprising an agent that blocks the cell cycle and an antibody
12/18/2002	EP1265631A1 Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant
12/18/2002	EP1265626A1 Method for reducing allergen-induced airway hyperresponsiveness
12/18/2002	EP0946721B1 Human growth gene and short stature gene region
12/18/2002	EP0925503B1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
12/18/2002	EP0904296B1 Monoclonal antibody that detects apoptotic antigen
12/18/2002	EP0876478A4 Monoclonal antibody to herpes simplex virus and cell line producing same
12/18/2002	EP0866803B1 Transferrin receptor protein of moraxella
12/18/2002	EP0784485B1 VACCINE COMPOSITIONS containing partially deacetylated chitin
12/18/2002	EP0769018B1 Helicobacter proteins and vaccines
12/18/2002	EP0662150B1 Maspin, a novel serpin with tumor suppressing activity
12/18/2002	EP0641385B1 Development of dna probes and immunological reagents of human tumor associated antigens
12/18/2002	EP0551440B1 Design of bioactive peptides based on immunoglobulin structure
12/18/2002	EP0521996B1 Catalytic antibody components
12/18/2002	CN1385532A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385529A Expression system utilizing self-schizolysis fusing protein and novel reduction polypeptide
12/18/2002	CN1385526A Precursor gene of ink chest wasp aptoxin bematolysis peptide, its coded polypeptide and preparation process thereof
12/18/2002	CN1385525A Precursor gene of frontal spot wasp calmative peptide, its coded polypeptide and preparation process
12/18/2002	CN1385443A Humanized liver cancer monoantibody, its preparation process and use
12/18/2002	CN1385442A Compound yolk antibody capable of resisting fowl bacterial blight and its preparation and use
12/18/2002	CN1385441A Novel human lymphokine, its coding sequence and use
12/17/2002	US6495740 Manipulation of cellulose and/or β-1,4-Glucan
12/17/2002	US6495736 Compositions and methods for increasing bone mineralization
12/17/2002	US6495666 Polypeptide composing human chimeric antibody
12/17/2002	US6495519 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
12/17/2002	US6495513 Morphogen-enhanced survival and repair of neural cells
12/17/2002	US6495359 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
12/17/2002	US6495356 Beryllofluoride analogues of acyl phosphate polypeptides
12/17/2002	US6495345 Surface antigen
12/17/2002	US6495343 Cloning and recombinant production of CRF receptor(s)
12/17/2002	US6495335 Monitoring using adduct of amyloid protein modified with malonaldehyde
12/17/2002	US6495334 Reacting a sample obtained from poultry with a truncated sef14 antigen to permit anti-salmonella enteritidis antibodies to bind antigen; presence of antibody/antigen binding complex indicates infection
12/17/2002	US6495332 Methods and compositions for ameliorating the symptoms of sepsis
12/17/2002	US6495331 Regulation of cytokine production such that allergic inflammation is thereby treated by administering a compound which interacts with mekk/jnkk signal transduction pathway
12/17/2002	US6495330 Determining the level of p-type inositol phosphoglycans in a biological sample obtained from the patient, wherein said p-type ipgs are capable of activating pyruvate dehydrogenase phosphatase, by immunoassay
12/17/2002	US6495139 Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
12/17/2002	US6495138 PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
12/17/2002	US6495137 Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains
12/17/2002	US6495129 Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
12/17/2002	CA2303591C Method and compositions for preventing or reducing hiv infection
12/17/2002	CA2080260C Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof
12/17/2002	CA1341411C Method for producing fv fragments in eukaryotic cells
12/17/2002	CA1341410C Recombinant acquired immune deficiency syndrome (aids) viral envelope protein and method of testing for aids
12/17/2002	CA1341409C Cloning and expression of htlv-iii dna
12/15/2002	CA2390327A1 Method
12/12/2002	WO2002099135A1 Method to measure gene expression ratio of key genes
12/12/2002	WO2002099119A2 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002099100A2 Method of production of a protein in cells which inducibly express the cell cycle inhibitor protein, p21
12/12/2002	WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002	WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002	WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002099069A2 Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
12/12/2002	WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002098921A1 Recombinant antibodies against infectious bursal disease virus (ibdv)
12/12/2002	WO2002098920A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002	WO2002098908A2 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
12/12/2002	WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002	WO2002098897A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002	WO2002098531A1 Methods for purifying highly anionic proteins
12/12/2002	WO2002098460A1 Compositions and methods for treating hyperimmune response in the eye
12/12/2002	WO2002098459A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
12/12/2002	WO2002098450A1 Altering an immune response by influencing the interaction of lair with its ligand
12/12/2002	WO2002098441A2 Method of treating metabolic disorders using neuronatin polypeptides
12/12/2002	WO2002098421A1 Novel treatment for neurological and psychiatric disorders
12/12/2002	WO2002098370A2 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
12/12/2002	WO2002098362A2 Use of rank antagonists to treat cancer
12/12/2002	WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002	WO2002098346A2 Method and pharmaceutical composition for the treatment of multiple sclerosis
12/12/2002	WO2002086058A9 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
12/12/2002	WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002	WO2002076494A3 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
12/12/2002	WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002	WO2002068623A3 Genes encoding proteolytic enzymes from aspargilli
12/12/2002	WO2002067848A3 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE
12/12/2002	WO2002064161A3 Method and compositions for immunization with the pseudomonas v antigen

1 ... 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 ... 1494